Why the study?
Are circulating monocyte-platelet aggregates a more sensitive marker of in vivo platelet activation than platelet surface P-selectin?
Population
Baboons and humans
Comparison
Measurement of circulating monocyte-platelet… vs Measurement of platelet surface P-selectin
Design
Other
Authors
Loading...
May enhance detection of platelet activation in practice; leaves open prospective outcome validation.
Are circulating monocyte-platelet aggregates a more sensitive marker of in vivo platelet activation than platelet surface P-selectin?
Circulating monocyte-platelet aggregates serve as a more sensitive biomarker for in vivo platelet activation compared to platelet surface P-selectin.
Michelson et al. (2001) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: